key: cord-0909112-kxvoi7os authors: Visca, Dina; Migliori, Giovanni Battista; Dinh-Xuan, Anh Tuan; Centis, Rosella; Belli, Stefano; Vitacca, Michele; Aliani, Maria; Zampogna, Elisabetta; Feci, Davide; Pignatti, Patrizia; Zappa, Martina; Saderi, Laura; Sotgiu, Giovanni; Spanevello, Antonio title: The Role of Blood Gas Analysis in the Post-Acute Phase of COVID-19 Pneumonia date: 2021-06-17 journal: Arch Bronconeumol DOI: 10.1016/j.arbres.2021.06.003 sha: d65bc6cb321f51c31e562e98194beccaf814f3e5 doc_id: 909112 cord_uid: kxvoi7os nan Data are expressed as number (%) and Mean ± SD or median interquartile range (IQR). a Denominator corresponds to total number of patients for whom data are available. b Previous history of TB. BMI: body max index; LoS: length of stay; TB: tuberculosis; COPD: chronic obstructive pulmonary disease; ICU: intensive care unit: NIV: non-invasive ventilation. COVID-19 survivors discharged from medical wards after a negative molecular test for SARS-CoV-2 were admitted to four clinical centres of the Istituti Clinici Scientifici Maugeri, Italy, and enrolled between April 1st and September 1st, 2020 to undergo clinical evaluation and multidisciplinary rehabilitation. The rehabilitation programme was implemented following the Italian position paper 16 : interventions were chosen considering age, clinical severity, length of immobilization, and comorbidities. 16 The study was approved by the central ethical committee (CEC2279). Clinical, radiological, and functional data were collected (Tables 1 and 2 ). Quantitative variables were described with means (standard deviations, SD) or medians (Interquartile ranges, IQR) in case of parametric or non-parametric distribution, respectively. Absolute and relative (percentage) frequencies were used to describe qualitative variables. Student t or Mann-Whitney test was computed to assess differences for parametric and non-parametric quantitative One-hundred and forty-five consecutive patients were recruited. The mean (SD) age was 70 (10.8) years and 99 (68.3%) patients were male; 21 (14.5%) had preexisting pulmonary disease (1 TB sequelae, 13 COPD, 7 asthma) and 34 (45%) were current or former smokers. Overall, 59 (40.7%) CARDS patients were originally discharged from ICU and 86 patients from non-ICU departments; among patients from non-ICU departments 30 (34.9%) underwent both non-invasive ventilation (NIV) and supplemental oxygen, 47 (56.7%) supplemental oxygen only, and 9 (10.5%) did not receive any therapies (Table 1) . Blood gases analysis was performed at admission or discharge in 137 (94.5%) and 66 (45.5%) patients, respectively ( Table 2 ); blood gases analysis was carried out both at admission and at discharge only in 58 (40%) patients ( Table 2) . No statistically significant differences were observed for intrapulmonary gases exchanges (SaO 2 , PaO2, PaCO2, P/F, AaDO 2 ) respiratory rate D-dimer between patients originally intubated when compared with those non-intubated during the acute COVID-19 phase ( Table 2) . A statistically significant post-rehabilitation improvement was observed in 58 patients evaluated with ABG both at admission and at discharge, for the following parameters: AaDO 2 (p: 0.004), Ddimer (p: 0.0003), respiratory (p: 0.003) and heart rate (p < 0.0001) but not for P/F (Table 1 ). These findings are confirmed among the 33/58 patients not ICU-admitted (AaDO 2 (p: 0.01), D-dimer (p: 0.0004), respiratory (p: 0.02) and heart rate (p < 0.0001) and not on P/F), while among the 25/58 patients originally admitted at ICU the AaDO 2 , D-dimer and respiratory rate lose the statistical significance ( Table 2) . Stratifying further these 58 patients by gender, age, length of stay (LoS) of hospital rehabilitation, BMI, smoking history and hypertension, AaDO 2 retains statistical significance in males (p: 0.002), aged > 70 years (p: 0.03), LoS < 24 days (p: 0.002), obese (p: 0.007), smokers (p: 0.02) and those affected by hypertension (p: 0.002). Our preliminary data on patients admitted for rehabilitation after recovery from COVID-19 suggest the following: a) The finding that intrapulmonary gases exchanges between originally intubated vs non-intubated patients during the acute COVID-19 phase do not differ significantly may suggest an atypical ARDS, although the effect of both the selection process and the small sample size cannot be excluded. b) The D-dimer as well presents no differences between the two groups of patients described above, potentially suggesting a multifactorial damage (alveolar damage, parenchymal damage and vascular damage): more damage would be expected among the previously intubated patients, likely to have suffered a more severe acute COVID-19 phase. c) In patients with ABG both at admission and discharge (n = 58), a statistically significant improvement was observed at discharge for AaDO 2 gradient and the same results were confirmed for 33/58 patients not ICU-admitted. By contrast, AaDO 2 gradient lost the statistical significance among the 25/58 CARDS patients originally admitted at ICU. This might suggest that AaDO 2 is more sensitive than P/F in the COVID-19 post-acute phase to monitor the lung damage in those not admitted to the ICU. d) Stratifying further these 58 patients AaDO 2 gradient retains statistical significance in males, aged > 70 years, LoS < 24 days, obese, smokers and those affected by hypertension suggesting it may be a sensitive marker in severe patients. e) Alveolar-to arterial oxygen, which can be calculated knowing PaO 2 , PaCO 2 and FiO 2 , can provide a more accurate evaluation of hypoxemia than P/F, because this could mirror changes in PaO 2 , FiO 2 or both. 12 More evidence is needed to understand the role of the AaDO 2 gradient as a marker of lung function impairment. Case reports from post-mortem findings and biopsies showed mononuclear inflammation and frequently diffuse alveolar damage, with necrosis of alveolar epithelial cells, hyaline membrane formation, and hyperplasia of type II pneumocytes. In addition, consolidations due to fibroblastic proliferation with extracellular matrix and fibrin forming clusters in airspaces, as well as vascular damages, were described. 8 All together alveolar, epithelial and vascular impairment could justify either ventilation-perfusion mismatch or intra-pulmonary shunting with an increase in AaDO 2 . In our study, the AaDO 2 gradient might improve in the medium-term among the patients previously admitted at ICU (or remained unchanged due to irreversible damage of the lungs). Additional studies are needed to ideally plan a longer follow-up ABG in monitoring the COVID-19 post-acute phase. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors The authors declare to have no conflict of interest directly or indirectly related to the manuscript contents. COVID-19 ICS Maugeri IRCCS network, et al. Management and outcomes of post-acute COVID-19 patients in Northern Italy Coronavirus disease-19: an interim evidence synthesis of the world association for infectious diseases and immunological disorders (Waidid) COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David An evidence based evaluation of problems Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance 12 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan China: a single-centered, retrospective, observational study Acute respiratory distress syndrome: the Berlin Definition. ARDS Definition Task Force Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies Ventilatory ratio in hypercapnic mechanically ventilated patients with COVID-19-associated acute respiratory distress syndrome Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study Respiratory mechanics and gas exchange in COVID-19-associated respiratory failure Functional impairment during post-acute COVID-19 phase: preliminary finding in 56 patients Pulmonary rehabilitation in patients recovering from COVID-19 Lung function testing during COVID-19 pandemic and beyond. Recommendation from ERS Group 9.1 (Respiratory function technologists/Scientists) Basing respiratory management of coronavirus on physiological principles Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: The Italian Position Paper The authors thank Prof. Nicolino Ambrosino for his advice in preparing the manuscript.